We are live on
!
Find out more
ZVSA
ZyVersa Therapeutics
ZVSA
ZVSA
Delisted
ZVSA was delisted on the 16th of July, 2025.
7 hedge funds and large institutions have $84.9K invested in ZyVersa Therapeutics in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
17% more funds holding
Funds holding: 6 → 7 (+1)
1.08% less ownership
Funds ownership: 1.23% → 0.15% (-1.1%)
53% less capital invested
Capital invested by funds: $181K → $84.9K (-$96.6K)
Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$22.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$12.5K |
| 3 |
HF
HRT Financial
New York
|
+$9.93K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$9.45K |
| 5 |
Jane Street
New York
|
+$9.13K |
Top Sellers
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$145K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$13.5K |